SIp (sex-limited protein) is a mouse serum protein encoded by a major histocompatibility complex class Iml gene. It is considered to be a product of a duplicated complement component C4 gene, but without functional activity.
S region of the H-2d or H-2s haplotype only but is constitutively expressed in some wild-type-derived mice (1) (2) (3) (4) . Although the SIp gene is thought to be a duplication of the C4 gene with about 95% homology to C4 at both the DNA and the protein level (7, 8) , the product of this gene is so far considered to be nonfunctional. This is based on experiments in which Slp could not restore the hemolytic activity of C4-deficient guinea pig serum (9) and in which Slp, unlike C4, showed resistance to cleavage by activated human Cis (8, 9) .
A mutation downstream from the C1s cleavage site was thought to be the cause of the hemolytic inactivity of Slp (10) . A more likely explanation for the apparent nonfunctional behavior of Slp, however, is incompatibility between mouse Slp and heterologous C1s. Similar species incompatibility has been described for mouse C4 and guinea pig Cis and C2 (11) .
Earlier studies demonstrated that a fraction of mouse serum prepared by precipitation with a critical concentration of polyethylene glycol [11% (wt/vol) PEG 6000] underwent "spontaneous" activation, resulting in the generation of functional membrane attack complexes (MACs) that were hemolytic for a broad panel of heterologous erythrocytes, including those from rabbits and sheep (12, 13) . The generation of functional MACs by this pathway was found to be C5-dependent, EDTA-resistant (i.e., Ca2+/Mg2+-independent; ref. 12) , and regulated in serum by C1 inhibitor (Cl-INH; ref. 14) . Thus far, this type of activation seems to be restricted to the mouse system, since guinea pig, human, rabbit, and rat sera do not become hemolytically active upon similar treatment. This paper presents a model of this EDTA-resistant complement activation pathway in mouse serum. The strong correlation between the MHC haplotype and the hemolytic activity suggested an involvement of Slp. Evidence is presented that Slp plays an essential role in this activation pathway, and the role other C components play is evaluated and discussed. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. columns] to be described elsewhere. C5 was purified from male (BALB/c x Swiss)F1 mice as described (15) . Cobra venom factors (CVFs) were purified from the venoms of the Egyptian cobra Naja haje (V 4254; Sigma) and the common Indian Cobra Naja naja (V 4378; Sigma) by a one-step Mono Q anion-exchange procedure (16) . CVF activities were assessed by using undiluted mouse serum as target for CVF activation (17) . PEG 6000 was obtained from Fluka.
MATERIALS AND METHODS
PEG-Induced Complement Activation. PEG precipitationinduced complement activity was determined by using the optimal conditions described by Van Dijk et al. (12) . Sera were diluted 1:10 in ice-cold VSB/EDTA containing 12.1% (wt/vol) PEG 6000 and for "direct" assay spun at 4000 X g and 40C for 60 min or, for "indirect assay," first mixed with an equal volume of Slp-deficient mouse serum (C3H/FeJ serum) and subsequently diluted and spun. Precipitates were reconstituted to the original serum volume in VSB/EDTA and, after incubation at 41'C for 45 (18) . To deplete C2/factor B, mouse serum was heat-inactivated for 30 min at 48°C (19) ; after this treatment classical and alternative pathway activities were undetectable, whereas 60% of functional Slp activity was retained. To deplete C3 or C3 and C5, mouse serum was treated with CVF from N. haje or N. naja, respectively (5 ,ug/ml of serum; 30 min at 37°C; ref. 17 ). C3 depletion was complete after treatment with either CVF; C5 was undetectable after N. naja CVF treatment, but no reduction in C5 activity was observed after treatment with CVF from N. haje (17) . Slp was depleted by heat-inactivation for 30 min at 52°C (2). C3/C4 depletion was performed by methylamine treatment (20) . No classical or alternative pathway activities were detectable after methylamine treatment. Depletion of the components was checked by hemolytic assays for total complement activity (21), C1 (18) , and C3 and C5 (15 1, panel 2) . The 020 mice showed the highest hemolytic activity, whereas mice with low plasma Slp levels (BxA-10 and AxB-2) correspondingly exhibited poor hemolytic activity.
Castration and Testosterone Treatment. To study the sexhormone dependency of the PEG precipitation-induced complement activation, male mice were castrated at the age of 10 weeks. Three weeks later mice were bled and serum was assayed in the indirect activation assay. Six weeks after castration, mice received daily injections of testosterone for 2 weeks. One day after the last injection the mice were bled for serum. Castration abolished or largely diminished the PEG precipitation-induced hemolytic activity, and testosterone injections reversed this effect of castration (Table 1) .
Age Dependency. As shown above, the expression of the PEG precipitation-induced hemolytic activity is dependent on the presence of the male sex hormone testosterone. To study the relation between the PEG precipitation-induced hemolytic activity and maturity, mice of different ages were bled for serum and tested in the direct and the indirect assay. Hemolytic activity was first detectable 6 weeks after birth and reached maximal values at 10 weeks of age (Fig. 1) .
Purified Sip. The correlation of hemolytic activity with the SIp allele of the H-2d and H-2s haplotypes-and, within these haplotypes, with testosterone levels and age-gives strong evidence that Slp is an essential component in this EDTAresistant, PEG precipitation-induced complement activation.
Proc. Natl. Acad. Sci. USA 89 (1992) Final proof was given by induction of hemolytic activity in an 11% PEG precipitate of Slp-deficient C3H/FeJ serum after addition of FPLC-purified Slp (specific activity, 23 U/pug; Fig. 2A ).
Role of Other Complement Components. The role of other complement components in the Slp-dependent complement activation pathway was studied by addition of purified complement components or selective depletion of individual components. Purified mouse C5 added to C5-deficient DBA/2 serum restored the PEG precipitation-inducible activity ( Fig. 2A) , as well as total hemolytic activity (15) .
Depletion of mouse serum of C1 (by precipitation with PEG), C2 and factor B or Slp (by heat inactivation), or C3/C5 (by CVF treatment) abrogated the PEG precipitation-induced complement activity (Fig. 2B) . C3/C4 inactivation by methylamine slightly reduced the hemolytic activity, but selective C3 depletion by CVF of N. haje did not affect the PEG precipitation-induced hemolytic activity (Fig. 2B) (12) . A further conclusion may be that C4 is not limiting in the PEG precipitation-induced complement activation, since sera from C57BL/6 males, which combine C5 sufficiency with the C4-high allele, were nevertheless nonhemolytic. With respect to a role of C2 and factor B, no conclusion can be drawn since these components are not polymorphic in these mice (3). In the indirect assay, which was performed after mixing test serum with an equal volume ofC5-sufficient, Slp-deficient serum, a total concurrence between hemolytic activity and a documented presence of antigenic Slp was observed ( Table 1 , panel 1). This sustained our hypothesis that Slp was necessarily involved in the PEG precipitationinduced complement activation.
To diminish the effect of non-MHC-related differences in genetic background of mice on their PEG-induced hemolytic activities, several congenic mice and mice with high or low plasma Slp levels were tested. Of congenic mice differing only in the central MHC region, only those expressing Slp exhibited hemolytic activity, and their reported plasma Slp levels corresponded with levels of hemolytic activity (Table  1, Castration of serum donors diminished or abolished, and testosterone treatment virtually restored, PEG precipitationinduced hemolytic activities. These observations are completely in line with the reported control of Slp expression by male sex hormones (5, 6) . Furthermore, the late appearance (at 6 weeks) of the PEG precipitation-induced hemolytic activity and its increase with the age of serum donors parallel with the reported levels of antigenic Slp (Slp appears in plasma when mice are about 6 weeks old and reaches maximal levels by 12 weeks; ref. 24) but not with levels of C4 (maximal levels are already reached at an age of S weeks; ref. 24) . All these results strongly suggest that Slp, and not C4, is the limiting factor in the PEG precipitation-induced complement activation. Slp (3 ,g/ml) and C5 (50 j&g/ml), respectively, and tested for hemolytic activity. (B) Sera from male (BALB/c x Swiss)Fl mice were selectively depleted of complement components and tested for PEG precipitation-induced hemolytic activity in the direct assay. Depletions: C1, prior precipitation with 3.5% PEG 6000; C2/factor B, heat inactivation at 48°C for 30 min; C3, treatment with CVF from N. haje (selectively C3-depleting); C3/C5, treatment with CVF from N. naja (C3-and C5-depleting); Slp, heat inactivated at 52°C for 30 min (activity was measured in the indirect assay using C3H/FeJ serum as Slp-deficient serum); C3/C4, methylamine-treated serum. Assays were carried out in duplicate and values are expressed as percentages (mean + SEM; n = 2) of corresponding activities in untreated serum.
Immunology: van 
Definite evidence for the essential role of Sip in the PEG precipitation-induced mouse complement activation came from the substitution experiment, which showed that FPLCpurified Sip rendered a PEG precipitate of Slp-negative C3H/FeJ serum hemolytic (Fig. 2A) .
The involvement of other complement components in the Slp-dependent activation pathway was studied by addition or selective depletion of different complement components in serum before testing. Fig. 2 indicates that C1, C2 and/or factor B, and C5, but not C3 and C4, are essential in the induction of Slp-dependent hemolytic activity. The reduction ofactivity after methylamine treatment might be explained by partial inactivation of Slp, which, like C3 and C4, has a reactive thioester bond. Moreover, the reactive thioester bond may be only partially essential for this type of activation, but binding to the target cell may enhance the efficiency of lysis by targeting activated C5 to the cell membrane. The functional activity of Sip, as tested with Slp-deficient serum, is lost by heating mouse serum at 520C, which is in line with a reported loss of SIp antigenicity at that temperature, whereas C4 loses its antigenicity and hemolytic activity only after heating at 70TC (2) . to Sip appears to be also relatively EDTA-resistant (the activation proceeds in the presence of up to 30 mM EDTA; data not shown). Cls may now additionally activate C2, which, in the activated Sip-C2 complex, is capable of activating C5 directly, thereby bypassing C3. Activation of C5 and subsequent binding of C6 result in the formation of C36. This complex, in concert with complement components C7 through C9, gives rise to lysis of heterologous erythrocytes by MAC formation. In human serum, a form of C3-bypass activation has been described in which a C4b-C4b dimer instead of a C4b-C3b complex participates in the C5 convertase (25) . It is possible that in our model a similar Sip dimer or an Slp-C4 complex, rather than a single Sip molecule, is an essential part of the C5 convertase.
As yet there is no direct indication that the Slp-induced complement activation observed after PEG-precipitation is SIp C1o Slpi () (26, 27) Sip and mouse C4 may be considered to be analogues of human C4A and C4B, which are also the products of two genes but are more homologous than their mouse counterparts (3). C4A and C4B differ significantly in their activity, resulting from a divergent substrate specificity (28) and also with respect to C3 conversion. Deficiency of human C4A has been associated with immune complex-mediated disease, especially systemic lupus erythematosus (SLE) (28) . The shown that the C4b-C2a complex is able to directly activate C5 in the absence of C3 (30) .
In conclusion, our results indicate that Sip, which has long been considered to be a nonfunctional mouse serum protein, is in fact an active complement component involved in the generation of hemolytic MACs via an activation pathway that bypasses C3. The putative importance of this type of activation at sites of inflammation and in immune-complex handling in man as well as in mouse is intriguing.
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